Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026 - Medical Digest & Congress Report

Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026 - Medical Digest & Congress Report | Wave AI Podcast Notes